Information  X 
Enter a valid email address

Angle PLC Ord 10P (AGL)

Related News

25-Jul-2018 02:50 PM

Angle losses deepen on increased investment spend

Liquied biopsy company Angle posted a deeper annual loss, owing to planned investment in its offering. Pre-tax losses for the year through April amounted to £7.6m, compared to losses of £6.3m a year earlier. Angle said an FDA clinical study
26-Jun-2018 08:10 AM

Broker Forecast - finnCap issues a broker note on Angle PLC

finnCap today reaffirms its corporate investment rating on Angle PLC (LON:AGL) and raised its price target to 110p (from 108p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
19-Apr-2018 11:10 AM

Broker Forecast - finnCap issues a broker note on Angle PLC

finnCap today reaffirms its corporate investment rating on Angle PLC (LON:AGL) and set its price target at 108p. Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
31-Jan-2018 09:23 AM

Angle reports operational losses widen

Angle plc, a world-leading liquid biopsy company, reported revenues of £0.2m for the six months ended 31 October 2017 but losses from continuing operations widened to £3.4m. The company noted several important operational highlights for the p
23-Jan-2018 10:56 AM

Angle PLC to present on 28 February 2018 at the Shares and AJ Bell Spotlight Evening in Edinburgh

If you are looking for some new investment ideas for 2018, then come along to the Shares and AJ Bell Investor Evening in Edinburgh on Wednesday 28 February 2018. Directors from London Stock Exchange listed companies will present their latest plans regardi
23-Jan-2018 09:33 AM

Angle PLC to present on 20 February 2018 at the Shares and AJ Bell Spotlight Evening in Manchester

If you are looking for some new investment ideas for 2018, then come along to the Shares and AJ Bell Investor Evening in Manchester on Tuesday 20 February 2018. Directors from London Stock Exchange listed companies will present their latest plans regardin
16-Jan-2018 07:52 AM

Professor to present webinar on use of ANGLE's Parsortix

ANGLE has announced that Professor Stuart Martin from the University of Maryland School of Medicine, USA, will be presenting a webinar describing his breakthrough work using the Parsortix system to test drugs on live circulating tumour cells as was descri
08-Jan-2018 09:48 AM

ANGLE reports new research on Parsortix

ANGLE said it was delighted to announce that the University Medical Centre Hamburg-Eppendorf together with the Medical University of Graz and the Science for Life Laboratory, Stockholm University had published results of work demonstrating that the comp
28-Nov-2017 09:20 AM

Study shows out-performance of Parsortix, says ANGLE

ANGLE said its Parsortix system is the subject of a further peer-reviewed publication in the journal Oncotarget. It said this details work undertaken by Prof. Robert Zeillinger's Molecular Oncology Group at the Medical University of Vienna (Vienna).
23-Nov-2017 08:11 AM

ANGLE collaboration with Philips

ANGLE has established a collaboration with Philips to develop liquid biopsy solutions. Philips has successfully secured a European Union research grant worth €6.3 million, of which £0.4 million will flow to ANGLE. Philips has selected ANGLE
13-Nov-2017 10:08 AM

Angle to present on 28 November 2017 at the Shares and AJ Bell Spotlight Evening in London

Looking for new investment ideas and want to meet senior directors of listed UK companies? Come along and join Shares and AJ Bell Media at one of their evening events in London on Tuesday 28 November 2017 and meet Angle, Royal Road Minerals, ThinCats,
01-Nov-2017 09:48 AM

ANGLE completes Axela deal and fundraising

ANGLE has announced that it has completed the fundraising and acquisition of certain assets of Axela Inc. At 9:48am: (LON:AGL) Angle PLC share price was -1.13p at 37.5p Story provided by StockMarketWire.com...
31-Oct-2017 02:20 PM

All resolutions passed at AGM of Angle

Angle has confirmed that all resolutions were passed by shareholders at today's Annual General Meeting. At 2:20pm: (LON:AGL) Angle PLC share price was 0p at 39.25p Story provided by StockMarketWire.com...
30-Oct-2017 01:13 PM

Angle shareholders approve resolutions at GM

Angle has confirmed that the resolutions put to shareholders at the General Meeting earlier today, in respect of the acquisition, placing and general subscription, were duly passed. At 1:13pm: (LON:AGL) Angle PLC share price was -0.63p at 39.38p St
23-Oct-2017 08:05 AM

ANGLE notes new report on Parsortix

ANGLE has announced that the Centre for Women's Health Tuebingen, Germany, has presented the first report on a successful establishment of a protocol for detecting disseminated tumour cells (DTCs) using cancer patient bone marrow with the Parsortix s
17-Oct-2017 07:53 AM

ANGLE welcomes new peer review of Parsortix

ANGLE has announced that its Parsortix system is the subject of a peer-reviewed publication in the journal Oncotarget detailing work undertaken by ANGLE's customer, University Hospital Muenster in Germany. ANGLE said Muenster undertook a detailed ev
09-Oct-2017 08:12 AM

ANGLE's Parsortix showcased at CTC conference

ANGLE's Parsortix system was widely showcased by the company's customers and key opinion leaders in the field of circulating tumour cells in presentations at Europe's leading CTC conference, the Third International Advances in Circulating
05-Oct-2017 01:46 PM

ANGLE successfully raises £12.2m through various placings

ANGLE has confirmed that the Company successfully raised approximately £12.2m (before expenses) with new and existing investors consisting of 3,757,146 EIS/VCT Placing Shares, 25,680,006 General Placing Shares, 772,857 General Subscription Shares an
05-Sep-2017 12:20 PM

Broker Forecast - finnCap issues a broker note on Angle PLC

finnCap today initiates coverage of Angle PLC (LON:AGL) with a corporate investment rating and price target of 100p. Story provided by StockMarketWire.com...
04-Sep-2017 07:54 AM

ANGLE welcomes new research on Parsortix

ANGLE said new research by Heinrich Heine University of Duesseldorf demonstrated the the measurement of key proteins in breast cancer using Parsortix, which may advise therapy decisions in breast cancer treatment. It said the research had been published
27-Jul-2017 09:38 AM

ANGLE losses widen

ANGLE's loss for the year ended 30 April rose to £6.4m - up from £5.1m last time. AMGLE said this reflected planned investment to advance clinical evidence through patient studies, FDA regulatory clearance and investment in marketing to
04-Jul-2017 07:24 AM

ANGLE confirms successful data in cancer studies

ANGLE , a world-leading liquid biopsy company, has announced positive headline results from 400 patient pelvic mass studies, in the US and Europe. It said the results demonstrated the potential for a Parsortix based blood test to out-perform current te
05-Jun-2017 07:43 AM

Parsortix success reported at ASCO, says ANGLE

ANGLE has announced that researchers have presented successful results from their work using the company's Parsortix system in colorectal cancer at the American Society of Clinical Oncology annual meeting in Chicago. ANGLE said the study, undertak
06-Jan-2017 03:39 PM

ANGLE Plc to present at the Growth and Innovation Forum 2017 in London on 31 January 2017

Andrew Newland the Chief Executive of ANGLE Plc (AGL) [LSE:AGL] the specialist medtech company, is to present at the Growth and Innovation Forum 2017 in London on 31 January 2017. The Growth and Innovation Forum 2017 is organised by Shares Magazine in pa
04-Jan-2017 07:48 AM

ANGLE schedules interims

ANGLE, the specialist medtech company, will be releasing its interim results for the six months ended 31 October on 26 January. Story provided by StockMarketWire.com...
 
Headlines
Top categories
Company finder

a d v e r t i s e m e n t